Centene, a company that provides a portfolio of services to government-sponsored health care programs, like Medicaid and Medicare, is continuing to grow, with new products and additional states in its programs.
"We're going to have probably a $65 billion run rate when this thing all gets closed, up from $48 billion last year," Centene CEO Michael Neidorff told Cramer in a Friday interview.
"You either grow or get paid a whole lot more for staying the same. And we want to grow," the CEO said.
The company beat expectations with its Tuesday earnings report, delivering a 29-cent beat off of a $1.88 basis. Revenue was slightly weaker than expected, but still up 12.5 percent year over year.
Cramer also pointed out that the company doesn't have to worry about commodity prices, doesn't have exposure to China and is "exactly the kind of stock that can work if you're concerned about an economy that might be losing steam."